The rae28 gene (rae28), also designated as mph1, is a mammalian ortholog of the Drosophila polyhomeotic gene, a member of Polycomb group genes (PcG). rae28 constitutes PcG complex 1 for maintaining transcriptional states which have been once initiated, presumably through modulation of the chromatin structure. Hematopoietic activity was impaired in the fetal liver of rae28-deficient animals (rae28−/−), as demonstrated by progressive reduction of hematopoietic progenitors of multilineages and poor expansion of colony forming units in spleen (CFU-S12) during embryonic development. An in vitro long-term culture-initiating cell assay suggested a reduction in hematopoietic stem cells (HSCs), which was confirmed in vivo by reconstitution experiments in lethally irradiated congenic recipient mice. The competitive repopulating units (CRUs) reflect HSCs supporting multilineage blood-cell production. CRUs were generated, whereas the number of CRUs was reduced by a factor of 20 in the rae28−/− fetal liver. We also performed serial transplantation experiments to semiquantitatively measure self-renewal activity of CRUs in vivo. Self-renewal activity of CRUs was 15-fold decreased in rae28−/−. Thus the compromised HSCs were presumed to reduce hematopoietic activity in the rae28−/− fetal liver. This is the first report to suggest that rae28 has a crucial role in sustaining the activity of HSCs to maintain hematopoiesis.
Skip Nav Destination
Article navigation
18 March 2002
Article|
March 18 2002
Polycomb Group Gene rae28 Is Required for Sustaining Activity of Hematopoietic Stem Cells
Hideaki Ohta,
Hideaki Ohta
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Search for other works by this author on:
Akihisa Sawada,
Akihisa Sawada
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Search for other works by this author on:
Ji Yoo Kim,
Ji Yoo Kim
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Search for other works by this author on:
Sadao Tokimasa,
Sadao Tokimasa
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Search for other works by this author on:
Seiji Nishiguchi,
Seiji Nishiguchi
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
Search for other works by this author on:
R. Keith Humphries,
R. Keith Humphries
4The Terry Fox Laboratory, British Columbia Cancer Agency and the Department of Medicine, University of British Columbia, Vancouver, BC, Canada V5Z 1L3
Search for other works by this author on:
Junichi Hara,
Junichi Hara
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Search for other works by this author on:
Yoshihiro Takihara
Yoshihiro Takihara
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
Search for other works by this author on:
Hideaki Ohta
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Akihisa Sawada
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Ji Yoo Kim
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Sadao Tokimasa
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Seiji Nishiguchi
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
R. Keith Humphries
4The Terry Fox Laboratory, British Columbia Cancer Agency and the Department of Medicine, University of British Columbia, Vancouver, BC, Canada V5Z 1L3
Junichi Hara
3Department of Developmental Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
Yoshihiro Takihara
1Department of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan
2Department of Medical Genetics, Research Institute for Microbial Diseases, Osaka University
Address correspondence to Yoshihiro Takihara, Dept. of Developmental Biology and Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, 3-3, Nakamichi-1, Higashinari, Osaka 537-8511, Japan. Phone: 81-6-6972-1181 (4116); Fax: 81-6-6973-5691; E-mail: [email protected]
*
Abbreviations used in this paper: BFU-E, erythroid burst-forming unit; CFU-C, CFU culture; CFU-E, erythroid CFU; CFU-GM, granulocyte/macrophage CFU; CFU-Mix, multilineage CFU; CFU-S12, day-12 CFU spleen; CRU, competitive repopulating unit; dpc, d post coitus; HDAC, histone deacetylase; HSC, hematopoietic stem cell; LTC-IC, long-term culture-initiating cell; PcG, Polycomb group.
Received:
November 15 2001
Revision Received:
January 29 2002
Accepted:
February 13 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 195 (6): 759–770.
Article history
Received:
November 15 2001
Revision Received:
January 29 2002
Accepted:
February 13 2002
Citation
Hideaki Ohta, Akihisa Sawada, Ji Yoo Kim, Sadao Tokimasa, Seiji Nishiguchi, R. Keith Humphries, Junichi Hara, Yoshihiro Takihara; Polycomb Group Gene rae28 Is Required for Sustaining Activity of Hematopoietic Stem Cells . J Exp Med 18 March 2002; 195 (6): 759–770. doi: https://doi.org/10.1084/jem.20011911
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement